ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Otsuka Holdings Co., Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 784 studies whose lead sponsor is Otsuka Holdings Co., Ltd. or one of 29 companies grouped under it. 57 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 30 registry names, not the registry’s. See them and correct one ↓

Compare Otsuka with AstraZeneca and Merck →

Pipeline: 25 programs

Each counted once: 25 with a study Otsuka Holdings Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 5 of 10 with the most live studies.

Program
sibeprenlimabPhase 3 · 6 live · Glomerulonephritis, IGA · primary completion Mar 2027☆ Track
ulotarontPhase 3 · 5 live · Schizophrenia · primary completion Mar 2028☆ Track
centanafadine hydrochloridePhase 3 · 5 live · Attention Deficit Disorder with Hyperactivity · primary completion May 2027☆ Track
futibatinibPhase 3 · 4 live · Cholangiocarcinoma · primary completion Dec 2026☆ Track
repinatrabitPhase 3 · 4 live · Phenylketonurias · primary completion Feb 2027☆ Track

5 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Otsuka Holdings Co., Ltd.’s own registered studies; Otsuka Holdings Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Otsuka Holdings Co., Ltd.’s studies test, most open studies first — 112 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 112; every drug is on its own page, and each page lists its sponsors.

Coming up

24 of Otsuka Holdings Co., Ltd.’s studies under way reach primary completion within a year, 10 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 8D
  3. J’27
  4. 3F
  5. 1M
  6. 1A
  7. 2M
  8. 2J
  9. J
  10. 3A
  11. 2S
  12. O
  13. 2N

The 12 nearest

Show 7 more

Add all 24 to your calendar (.ics) → With an account.

All 784 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now577%Recruiting 45 · Not yet recruiting 9 · Enrolling by invitation 3
  • Under way, not recruiting253%
  • Completed60077%
  • Stopped early8511%Terminated 75 · Withdrawn 10
  • Status unknown or other172%Status unknown 13 · Available 2 · Approved for marketing 2

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 4211
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 2326

By the year each study started; 135 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Otsuka Holdings Co., Ltd.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    297 studies →
  • Otsuka Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    143 studies →
  • Taiho Oncology, Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    66 studies →
  • Astex Pharmaceuticals, Inc.
    Acquired — became part of Otsuka Holdings Co., Ltd., Oct 11, 2013 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    45 studies →
  • Taiho Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    43 studies →
  • Korea Otsuka Pharmaceutical Co., Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    42 studies →
  • Otsuka Beijing Research Institute
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    36 studies →
  • Avanir Pharmaceuticals
    Acquired — became part of Otsuka Holdings Co., Ltd., Jan 13, 2015 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    13 studies →
  • Otsuka America Pharmaceutical
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • Bonafide Health
    Acquired — became part of Otsuka Holdings Co., Ltd., Nov 30, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • ReCor Medical, Inc.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Otsuka Pharmaceutical Europe Ltd
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Taiwan Otsuka Pharm. Co., Ltd
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • Transcend Therapeutics
    Acquired — became part of Otsuka Holdings Co., Ltd., 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • Otsuka Frankfurt Research Institute GmbH
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Otsuka Pharmaceutical, Inc., Philippines
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Pharmavite LLC
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Otsuka Medical Devices Co., Ltd. Japan
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Veryan Medical Ltd.
    Acquired — became part of Otsuka Holdings Co., Ltd., 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Visterra, Inc.
    Acquired — became part of Otsuka Holdings Co., Ltd., Aug 31, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • PT Otsuka Indonesia
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Otsuka Pharmaceutical Factory, Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Otsuka Australia Pharmaceutical Pty Ltd
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Otsuka Canada Pharmaceutical Inc.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Diatranz Otsuka Limited
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Korea Otsuka International Asia Arab
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Otsuka Novel Products GmbH
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Thai Otsuka Pharmaceutical Co., Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Otsuka Pakistan Limited
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Otsuka Holdings Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study

Focus areas

Conditions Otsuka Holdings Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 784. Browse all 784 →